[1]
H. Severina, N. Voloshchuk, N. Saidov, and V. Georgiyants, “Design, synthesis, molecular docking and anticonvulsant evaluation of 6-methyl-2-arylaminopyrimidin-4(3H)-one”, ScienceRise: Pharmaceutical Science, no. 2 (24), pp. 9–17, Apr. 2020.